News Chart Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

Delayed Hong Kong S.E. Other stock markets 07:31:38 23/05/2024 BST			5-day change	1st Jan Change
1.18 ^HKD	-3.28%		-4.07%	-27.61%

04-22	Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint	CI
04-22	Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment	MT

2a7751313306117b3bc1a8098311ba.3WaET3nOAv4ZBq_xBGtDSVEH8PcHefCCblFbdA8xaKQ.lTfzA02vT7dhNtq3fDg1fTNCx55_ErfxPh0KO0pjPJe4B-gpFqVSx3ht-g~c4da0ce3626de1246a111b6ea9910400